Bob Hopkins
Stock Analyst at B of A Securities
(0.75)
# 3,506
Out of 4,829 analysts
55
Total ratings
45%
Success rate
-39.29%
Average return
Main Sectors:
Stocks Rated by Bob Hopkins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | $220 → $255 | $156.44 | +63.00% | 5 | Nov 20, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $90 → $100 | $102.87 | -2.79% | 5 | Oct 22, 2024 | |
| SGHT Sight Sciences | Downgrades: Underperform | $10 → $4.5 | $3.21 | +40.19% | 4 | Sep 13, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $48 | $54.44 | -11.83% | 1 | Oct 11, 2021 | |
| ABT Abbott Laboratories | Maintains: Buy | $133 | $131.99 | +0.77% | 2 | Aug 31, 2021 | |
| LUNG Pulmonx | Upgrades: Buy | $72 | $3.68 | +1,856.52% | 2 | Mar 10, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Neutral | $242 → $253 | $561.43 | -54.88% | 7 | Sep 8, 2020 | |
| PEN Penumbra | Downgrades: Neutral | n/a | $297.55 | - | 2 | Sep 8, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $85 → $95 | $23.45 | +305.12% | 5 | May 22, 2020 | |
| JNJ Johnson & Johnson | Upgrades: Buy | n/a | $154.14 | - | 2 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $37 → $30 | $98.73 | -69.61% | 2 | Oct 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $105 | $85.81 | +22.36% | 7 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $83 | $31.88 | +160.35% | 6 | May 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $260 | $175.34 | +48.28% | 4 | Jan 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $59.01 | - | 1 | Nov 10, 2017 |
Inspire Medical Systems
Nov 20, 2024
Upgrades: Buy
Price Target: $220 → $255
Current: $156.44
Upside: +63.00%
Boston Scientific
Oct 22, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $102.87
Upside: -2.79%
Sight Sciences
Sep 13, 2023
Downgrades: Underperform
Price Target: $10 → $4.5
Current: $3.21
Upside: +40.19%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $48
Current: $54.44
Upside: -11.83%
Abbott Laboratories
Aug 31, 2021
Maintains: Buy
Price Target: $133
Current: $131.99
Upside: +0.77%
Pulmonx
Mar 10, 2021
Upgrades: Buy
Price Target: $72
Current: $3.68
Upside: +1,856.52%
Intuitive Surgical
Sep 8, 2020
Downgrades: Neutral
Price Target: $242 → $253
Current: $561.43
Upside: -54.88%
Penumbra
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $297.55
Upside: -
Tandem Diabetes Care
May 22, 2020
Maintains: Neutral
Price Target: $85 → $95
Current: $23.45
Upside: +305.12%
Johnson & Johnson
Apr 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $154.14
Upside: -
Oct 31, 2019
Maintains: Underperform
Price Target: $37 → $30
Current: $98.73
Upside: -69.61%
Aug 22, 2018
Maintains: Buy
Price Target: $98 → $105
Current: $85.81
Upside: +22.36%
May 22, 2018
Maintains: Buy
Price Target: $73 → $83
Current: $31.88
Upside: +160.35%
Jan 19, 2018
Reinstates: Buy
Price Target: $260
Current: $175.34
Upside: +48.28%
Nov 10, 2017
Upgrades: Neutral
Price Target: n/a
Current: $59.01
Upside: -